Ypsomed HY 2026/27 Group EBIT falls 34% to CHF 99.8 million

By Public Technologies
  • Ypsomed reported first-half 2026/27 net profit of CHF 85.5 million, while Group EBIT fell 34% to CHF 99.8 million.
  • Group sales dropped 12% to CHF 317.6 million, reflecting the divestments of Diabetes Care and Ypsotec.
  • Delivery Systems sales climbed 18% to CHF 286.6 million, with a record 30 new customer projects won.
  • Raised 2026/27 Delivery Systems guidance targets sales growth of 13%-16% and EBIT of CHF 220 million to CHF 240 million.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ypsomed Holding AG published the original content used to generate this news brief on November 11, 2026, and is solely responsible for the information contained therein.

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.
The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.
To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.